ArticleOncoimmunology2016
Resistance is futile: Targeting the inhibitory FcγRIIB (CD32B) to maximize immunotherapy.
Ali Roghanian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleOncoimmunology2016
Ali Roghanian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.